arrow
D

David Erlinge

Lund University
H指数:83
被引数:3.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Balance of non–Lp(a) apoB and Lp(a) with Coronary Plaque Phenotypes and MACE: Insights from PROSPECT II and CASABLANCA

非Lp(a) apoB与Lp(a)的平衡与冠状动脉斑块表型及MACE的关系:来自PROSPECT II和CASABLANCA的研究启示

2026-09-260
OA
Authors’ reply to: “Stent-Free Is Not Risk-Free: Risk-Defined DAPT After DCB-Only PCI in ACS”

作者对“无支架并非零风险:仅使用DCB的PCI术后ACS患者的风险定义DAPT”的回复

2026-08-040
OAAI
Drug-coated balloons versus drug-eluting stents for small non-complex de novo coronary artery lesions: A segment-level propensity score matched analysis from SCAAR

药物涂层球囊与药物洗脱支架治疗小直径非复杂原发冠状动脉病变:一项来自SCAR的节段水平倾向性评分匹配分析

2025-11-013
OAAI
Beta-Blockers after Myocardial Infarction with Normal Ejection Fraction
2025-11-014
PRE
Long-acting nitrate use before and after revascularization to evaluate angina in chronic coronary syndrome: a case-crossover study from SCAAR

慢性冠状动脉综合征中,在血运重建前后使用长效硝酸酯类药物评估心绞痛:一项来自SCAAR的病例交叉研究

2025-10-280
OAAI
Reply to the commentary by Dong et al.: Appraising the CCTA-SCAD study: Current challenges and future perspectives in diagnosing acute spontaneous coronary artery dissection

回复Dong等人的评论:评估CCTA-SCAD研究:急性自发性冠状动脉夹层诊断的当前挑战和未来展望

2025-10-080
PRE
Cardiometabolic outcomes with dapagliflozin after myocardial infarction by baseline ejection fraction: DAPA-MI

dapagliflozin治疗后射血分数不同的心肌梗死患者的心血管代谢结局:DAPA-MI

2025-09-010
OAAI
An in-depth analysis of coronary computed tomography angiography segmental findings in acute spontaneous coronary artery dissection – a prospective multicenter study

急性自发性冠状动脉夹层冠状动脉CT血管造影节段性发现的深入分析——一项前瞻性多中心研究

2025-08-280
OAAI
An update on the SWITCH-SWEDEHEART study

SWITCH-SWEDEHEART研究的最新进展

2025-07-080
PRE